N/A N=45 Basic Science

Impact of Pushrim Activated Power Assist Wheelchairs on Mobility Among People With Tetraplegia

Wheelchair Users

Bottom Line

View on ClinicalTrials.gov: NCT00281463 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Nov 2014

Primary outcome: Primary: Oxygen Consumption — 625 VO2 (ml/min)

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Pushrim Activated Power Assist (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: VA Pittsburgh Healthcare System
Primary completion: Mar 2007

Outcome Measures

Outcome	Result	p-value
PRIMARY Oxygen Consumption	415	—

Summary

The purpose of this three phase study is to evaluate a Pushrim Activated Power Assist Wheelchair (PAPAW). Phase I will examine whether the steady-state, metabolic energy efficiency for propelling a manual wheelchair with and without the device will be significantly different. In Phase II, wheelchair users will evaluate the PAPAW over activities of daily living course to determine its usability and acceptability and to identify areas for future development. Finally, in phase III, comparison of activities of daily living in the community will be made between the subjects when using their personal wheelchair and a PAPAW.

Eligibility Criteria

Inclusion Criteria

18 and 65 years of age
Full time wheelchair user
Diagnosis of Tetraplegia

Exclusion Criteria

Pressure sores
Shoulder pain that would prevent them from propelling a manual wheelchair
History of cardiopulmonary disease.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00281463). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.